Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2008 Aug;23(8):1125-30.
doi: 10.1007/s11606-008-0607-z. Epub 2008 Apr 29.

Recognition and management of chronic kidney disease in an elderly ambulatory population

Affiliations
Meta-Analysis

Recognition and management of chronic kidney disease in an elderly ambulatory population

Michael B Rothberg et al. J Gen Intern Med. 2008 Aug.

Abstract

Background: Chronic kidney disease (CKD) is a growing problem among the elderly. Early detection is considered essential to ensure proper treatment and to avoid drug toxicity, but detection is challenging because elderly patients with CKD often have normal serum creatinine levels. We hypothesized that most cases of CKD in the elderly would go undetected, resulting in inappropriate prescribing.

Objective: To determine whether recognition of CKD is associated with more appropriate treatment

Design: Retrospective chart review

Participants: All patients aged >/=65 years with a measured serum creatinine in the past 3 years at 2 inner city academic health centers.

Measurements: Estimated glomerular filtration rate (eGFR) calculated using the Modified Diet in Renal Disease equation, and for patients with eGFR < 60, documentation of CKD by the provider, diagnostic testing, nephrology referral and prescription of appropriate or contraindicated medications.

Results: Of 814 patients with sufficient information to estimate eGFR, 192 (33%) had moderate (eGFR < 60 mL/min) and 5% had severe (eGFR < 30 mL/min) CKD. Providers identified 38% of moderate and 87% of severe CKD. Compared to patients without recognized CKD, recognized patients were more likely to receive an ACE/ARB (80% vs 61%, p = .001), a nephrology referral (58% vs 2%, p < .0001), or urine testing (75% vs 47%, p < .0001), and less likely to receive contraindicated medications (26% vs 40%, p = .013).

Conclusions: Physicians frequently fail to diagnose CKD in the elderly, leading to inappropriate treatment. Efforts should focus on helping physicians better identify patients with low GFR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Key care measures in recognized and unrecognized renal insufficiency among patients with eGFR < 60 mL/min.

Similar articles

Cited by

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12859163', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12859163/'}]}
    2. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/01.ASN.0000013291.78621.26', 'is_inner': False, 'url': 'https://doi.org/10.1097/01.asn.0000013291.78621.26'}, {'type': 'PubMed', 'value': '11961022', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11961022/'}]}
    2. Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2002;13:1338–49. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJM199604113341502', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejm199604113341502'}, {'type': 'PubMed', 'value': '8596594', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8596594/'}]}
    2. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med. 1996;334:939–45. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(96)11445-8', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(96)11445-8'}, {'type': 'PubMed', 'value': '9217756', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9217756/'}]}
    2. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997;349:1857–63. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12965979', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12965979/'}]}
    2. Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244–52. - PubMed

Publication types

MeSH terms

Substances